Skip to content

An e-Health Intervention for Dutch Women with Stress Urinary Incontinence

An e-Health Intervention for Dutch Women with Stress Urinary Incontinence: an implementation Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25463
Enrollment
100
Registered
2018-01-16
Start date
2018-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress-urinary incontinence

Interventions

E-health intervention (Tät®- treatment of Stress Urinary incontinence) with pelvic floor muscle training and life style advices

Sponsors

Grotendeels eigen bijdrage afdeling vrouwenstudies Radboudumc.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged ¡Ý 18 years; Stress urinary incontinence or mixed urinary incontinence with predominantly stress urinary incontinence; Capable of understanding Dutch language; Internet access

Exclusion criteria

Exclusion criteria: Participation in another therapy program/ trial regarding stress urinary incontinence; Surgery for urinary incontinence six months prior to baseline; Pelvic floor muscle treatment from physiotherapist six months prior to baseline; Pregnancy; Malignancy in lower abdomen; Severely ill/ severe mental illness.

Design outcomes

Primary

MeasureTime frame
barriers and facilitators for implementation the e-health intervention (Tät®- treatment of Stress Urinary incontinence) for the treatment of stress urinary incontinence. Are these barriers and facilitators related to age and severity of incontinence?

Secondary

MeasureTime frame
the effect of an e-health intervention for the treatment and guidance of Dutch women with SUI on incontinence severity and quality of life and the technical data on the use of the intervention

Contacts

Public ContactLotte Firet

Radboudumc Primary Care

Lotte.Firet@radboudumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)